Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01399437 · ClinicalTrials.gov registry record
Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 64
- Enrollment target
NCT01399437 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 64 participants.
The verdict
NCT01399437 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
Background: \- A special brain circuit is important for helping us keeping an eye open for things that are going on around us, even when we are not directly paying attention to them. This circuit seems to work differently in people with schizophrenia than in other people, which may explain specific deficits with broad monitoring observed in people with schizophrenia. Researchers want to compare brain function in people with schizophrenia and healthy volunteers to find out more about how these brain circuits work and affect attention. Objectives: \- To study how the brain performs broad visual monitoring in people with schizophrenia. Eligibility: * Individuals between 18 to 55 years of age who have been diagnosed with schizophrenia. * Healthy volunteers between 18 and 55. Design: * Participants will be screened with physical and psychological exams. They will have a medical history. Tests for drug and alcohol use will also be done. * Participants will have two study visits. The first is a training visit and the second is a scanning visit. * At the training visit, participants will practice computer-based tests of focus, memory, and concentration. They will also answer questions about mood, psychiatric symptoms, and smoking habits. * At the scanning visit, participants will perform the computer-based tasks that they practiced at the training visit. They will have magnetic resonance imaging while they perform these tasks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2011-07-03 |
| Est. Completion | 2014-12-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01399437
The ClinicalTrials.gov registry entry for NCT01399437 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01399437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01399437 about?
NCT01399437 is a clinical study titled "Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia". Background: \- A special brain circuit is important for helping us keeping an eye open for things that are going on around us, even when we are not directly paying attention to them. This circuit seems to work differently in people with schizophrenia than in other people, which may explain specific...
What is the current status of trial NCT01399437?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2011-07-03. Estimated completion is 2014-12-24.
Who is sponsoring clinical trial NCT01399437?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.